Basal Cell Carcinoma-A Retrospective Descriptive Study Integrated in Current Literature.
Carmen GiugleaAndrei MarinIulia GavrilaAlexandra PaunescuNicoleta Amalia DobreteSilviu Adrian MarinescuPublished in: Life (Basel, Switzerland) (2023)
Basal cell carcinoma (BCC) is considered to be the most common cancer in humans. It has a slow growth rhythm, and for this reason, metastases are rare. For our retrospective study, we selected 180 patients from those who underwent surgery for a variety of skin tumours between January 2019 and August 2022 and whose histopathological examination revealed basal cell carcinoma. All surgeries were performed by plastic surgeons at the "St. John" hospital in Bucharest. The aim of this article is to provide observational data regarding BCC-in terms of histopathology and diagnostic and therapeutic management and to integrate these data into the current knowledge of this pathology.
Keyphrases
- basal cell carcinoma
- end stage renal disease
- healthcare
- electronic health record
- ejection fraction
- minimally invasive
- systematic review
- newly diagnosed
- papillary thyroid
- atrial fibrillation
- peritoneal dialysis
- squamous cell carcinoma
- blood pressure
- heart rate
- cross sectional
- squamous cell
- machine learning
- coronary artery bypass
- single cell
- percutaneous coronary intervention
- coronary artery disease
- data analysis
- surgical site infection
- acute care
- thoracic surgery
- patient reported
- drug induced